| Literature DB >> 32047825 |
Sofi Sonesson1, Joanna Kvist1,2, Jafar Yakob3, Henrik Hedevik1, Håkan Gauffin4.
Abstract
BACKGROUND: Arthroscopic meniscal surgery is a common orthopaedic procedure in middle-aged patients, but the efficacy of this procedure has been questioned. In this study, we followed up the only randomized controlled trial that has shown a 1-year benefit from knee arthroscopic surgery with an exercise program compared with an exercise program alone.Entities:
Keywords: knee arthroscopic surgery; meniscectomy; menisci; middle-aged; radiographic osteoarthritis
Year: 2020 PMID: 32047825 PMCID: PMC6985975 DOI: 10.1177/2325967119893920
Source DB: PubMed Journal: Orthop J Sports Med ISSN: 2325-9671
Figure 1.Patient enrollment and randomization. Exclusion criteria were locked knee or joint locking for more than 2 seconds more often than once a week, rheumatic or neurological disease, fibromyalgia, replacement of hip or knee joints, or a contraindication for surgery (body mass index >35 kg/m2 or a serious medical illness). Groups analyzed in the as-treated analysis: surgery group = a + c (total of 85 patients) and nonsurgery group = b + d (total of 61 patients).
Patient Characteristics at Baseline
| Surgery (n = 85) | Nonsurgery (n = 61) |
| |
|---|---|---|---|
| Age, mean ± SD, y | 55 ± 5 | 54 ± 6 | .443 |
| Sex, male/female, n | 43/42 | 39/22 | .109 |
| Duration of knee pain, median (IQR), mo | 7 (8) | 7 (8) | .839 |
| OA severity (Kellgren-Lawrence grade) | .369 | ||
| 0 | 30 (38) | 15 (25) | |
| 1 | 18 (23) | 19 (32) | |
| 2 | 31 (39) | 25 (42) | |
| 3 | 1 (1) | 1 (2) | |
| Sudden onset of pain | 47 (56) | 32 (55) | .927 |
| Mechanical symptoms | 58 (69) | 32 (54) | .071 |
| Age <55 y | 42 (49) | 32 (53) | .716 |
| Moderate to high physical activity level (PAS 4-6) | 27 (33) | 19 (33) | .960 |
Values are shown as n (%) unless otherwise indicated. IQR, interquartile range; OA, osteoarthritis; PAS, Physical Activity Scale.
Independent-samples t test.
Pearson chi-square test.
Mann-Whitney U test.
Fisher exact test.
Patient-Reported Outcome Measure Scores
| Baseline | 1 y | 3 y | 5 y | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Surgery | Nonsurgery |
| Surgery | Nonsurgery |
| Surgery | Nonsurgery |
| Surgery | Nonsurgery |
| |
| KOOSPAIN | ||||||||||||
| n | 84 | 60 | 78 | 48 | 70 | 44 | 65 | 35 | ||||
| Mean (95% CI) | 53.5 | 60.2 |
| 84.3 | 79.1 | .085 | 82.4 | 80.1 | .557 | 79.3 | 86.0 | .111 |
| KOOSSYMPTOMS | ||||||||||||
| n | 83 | 60 | 78 | 48 | 71 | 44 | 66 | 36 | ||||
| Mean (95% CI) | 58.5 | 62.7 | .176 | 82.1 | 78.9 | .274 | 82.5 | 78.5 | .269 | 77.1 | 85.6 |
|
| KOOSADL | ||||||||||||
| n | 83 | 59 | 78 | 48 | 71 | 42 | 64 | 36 | ||||
| Mean (95% CI) | 63.2 | 70.2 |
| 86.9 | 82.9 | .188 | 86.5 | 81.9 | .203 | 83.9 | 87.9 | .283 |
| KOOSSPORTS | ||||||||||||
| n | 83 | 59 | 78 | 48 | 71 | 44 | 65 | 35 | ||||
| Mean (95% CI) | 26.4 | 36.9 |
| 57.2 | 58.9 | .744 | 61.5 | 61.9 | .948 | 57.7 | 65.9 | .186 |
| KOOSQoL | ||||||||||||
| n | 84 | 59 | 78 | 48 | 71 | 44 | 65 | 36 | ||||
| Mean (95% CI) | 31.8 | 37.5 |
| 64.3 | 60.4 | .348 | 69.6 | 66.8 | .547 | 65.3 | 68.1 | .585 |
| EQ-5D | ||||||||||||
| n | 83 | 59 | 78 | 48 | 68 | 41 | 65 | 36 | ||||
| Mean (95% CI) | 0.61 | 0.65 | .264 | 0.83 | 0.83 | .873 | 0.86 | 0.80 | .134 | 0.81 | 0.86 | .181 |
| EQ-VAS | ||||||||||||
| n | 82 | 58 | 77 | 47 | 68 | 42 | 64 | 34 | ||||
| Mean (95% CI) | 60.9 | 65.9 | .157 | 77.2 | 76.1 | .716 | 78.7 | 76.9 | .623 | 79.0 | 83.5 | .160 |
Data are based on the total cohort of patients at each evaluation time point. Bolded values indicate statistical significance (P < .05). ADL, activities of daily living; EQ-5D, EuroQol 5 dimensions; EQ-VAS, EuroQol visual analog scale; KOOS, Knee injury and Osteoarthritis Outcome Score; QoL, quality of life.
Change in Patient-Reported Outcome Measure Scores
| Baseline to 1 y | Baseline to 5 y | 3 to 5 y | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Surgery | Nonsurgery | Between- | Adjusted | Surgery | Nonsurgery | Between- Group Difference | Adjusted | Surgery | Nonsurgery | Between- Group Difference | Adjusted | |
| KOOSPAIN | ||||||||||||
| n | 62 | 33 | 65 | 35 | 61 | 31 | ||||||
| Mean (95% CI) | 31.1 | 19.4 | 11.8 | .194 | 25.8 | 22.6 | 3.2 | .403 | –1.2 | 4.6 | 5.8 |
|
| |
| .500 | .058 | |||||||||
| KOOSSYMPTOMS | ||||||||||||
| n | 61 | 33 | 65 | 36 | 63 | 32 | ||||||
| Mean (95% CI) | 25.0 | 18.3 | 6.7 | .321 | 17.9 | 19.9 | 2.0 | .124 | –4.0 | 3.9 | 7.9 |
|
| | .057 | .625 |
| |||||||||
| KOOSADL | ||||||||||||
| n | 62 | 32 | 64 | 35 | 61 | 31 | ||||||
| Mean (95% CI) | 23.7 | 12.7 | 11.0 | .116 | 20.4 | 14.0 | 6.4 | .975 | –1.0 | 3.9 | 4.9 | .141 |
| |
| .134 | .124 | |||||||||
| KOOSSPORTS | ||||||||||||
| n | 62 | 33 | 65 | 34 | 62 | 31 | ||||||
| Mean (95% CI) | 32.2 | 23.8 | 8.4 | .767 | 30.7 | 24.3 | 6.4 | .934 | –2.4 | 0.8 | 3.1 | .372 |
| | .148 | .296 | .514 | |||||||||
| KOOSQoL | ||||||||||||
| n | 62 | 33 | 65 | 35 | 62 | 32 | ||||||
| Mean (95% CI) | 33.1 | 24.3 | 8.8 | .416 | 33.7 | 27.1 | 6.6 | .816 | –3.2 | 0.2 | 3.4 | .433 |
| | .095 | .217 | .409 | |||||||||
| EQ-5D | ||||||||||||
| n | 61 | 32 | 64 | 35 | 59 | 30 | ||||||
| Mean (95% CI) | 0.24 | 0.15 | 0.10 | .782 | 0.22 | 0.17 | 0.04 | .313 | –0.03 | 0.05 | 0.08 | .117 |
| | .076 | .433 | .062 | |||||||||
| EQ-VAS | ||||||||||||
| n | 60 | 31 | 63 | 33 | 59 | 30 | ||||||
| Mean (95% CI) | 15.8 | 10.2 | 5.6 | .870 | 18.4 | 16.7 | 1.7 | .479 | –0.1 | 4.5 | 4.6 | .105 |
| | .199 | .663 | .169 | |||||||||
Bolded values indicate statistical significance (P < .05). ADL, activities of daily living; EQ-5D, EuroQol 5 dimensions; EQ-VAS, EuroQol visual analog scale; KOOS, Knee injury and Osteoarthritis Outcome Score; QoL, quality of life.
Data from the cohort of patients who answered the questionnaire at baseline, the 1-year follow-up, and the 5-year follow-up.
Adjusted for overall mean scores at baseline.
Adjusted for overall mean scores at the 3-year follow-up.
Figure 2.Mean Knee injury and Osteoarthritis Outcome Score (KOOS)–Pain subscore at baseline, 1 year, 3 years, and 5 years according to treatment group.
Figure 3.Percentage of patients in each treatment group who showed the indicated change in the Knee injury and Osteoarthritis Outcome Score (KOOS)–Pain subscore from baseline to 5 years. Dotted horizontal lines indicate a 10-point change from baseline.
Results of 2-Way Analyses of Covariance
|
|
|
| Partial η2 Value |
| |
|---|---|---|---|---|---|
| Change in KOOSPAIN as DV (n = 99) | 0.361 | ||||
| Treatment group | 1 | 0.002 | .967 | 0.000 | |
| Mechanical symptoms | 1 | 5.100 | .026 | 0.051 | |
| Treatment group × mechanical symptoms | 1 | 5.634 | .020 | 0.057 | |
| KOOSPAIN at baseline (covariate) | 1 | 31.713 | <.001 | 0.252 | |
| Change in KOOSSYMPTOMS as DV (n = 100) | 0.291 | ||||
| Treatment group | 1 | 0.749 | .389 | 0.008 | |
| Mechanical symptoms | 1 | 1.183 | .279 | 0.012 | |
| Treatment group × mechanical symptoms | 1 | 4.322 | .040 | 0.044 | |
| KOOSSYMPTOMS at baseline (covariate) | 1 | 30.708 | <.001 | 0.244 | |
| Change in KOOSADL as DV (n = 98) | 0.403 | ||||
| Treatment group | 1 | 0.572 | .451 | 0.006 | |
| Mechanical symptoms | 1 | 2.761 | .100 | 0.029 | |
| Treatment group × mechanical symptoms | 1 | 5.706 | .019 | 0.058 | |
| KOOSADL at baseline (covariate) | 1 | 38.440 | <.001 | 0.292 | |
| Change in KOOSSPORTS as DV (n = 98) | 0.154 | ||||
| Treatment group | 1 | 0.019 | .890 | 0.000 | |
| Mechanical symptoms | 1 | 2.123 | .148 | 0.022 | |
| Treatment group × mechanical symptoms | 1 | 0.487 | .487 | 0.005 | |
| KOOSSPORTS at baseline (covariate) | 1 | 11.143 | .001 | 0.107 | |
| Change in KOOSQoL as DV (n = 99) | 0.204 | ||||
| Treatment group | 1 | 0.346 | .558 | 0.004 | |
| Mechanical symptoms | 1 | 2.003 | .160 | 0.021 | |
| Treatment group × mechanical symptoms | 1 | 1.817 | .181 | 0.019 | |
| KOOSQoL at baseline (covariate) | 1 | 15.048 | <.001 | 0.138 | |
| Change in EQ-5D as DV (n = 98) | 0.554 | ||||
| Treatment group | 1 | 0.455 | .502 | 0.005 | |
| Mechanical symptoms | 1 | 0.312 | .578 | 0.003 | |
| Treatment group × mechanical symptoms | 1 | 0.839 | .362 | 0.009 | |
| EQ-5D at baseline (covariate) | 1 | 109.670 | <.001 | 0.541 | |
| Change in EQ-VAS as DV (n = 95) | 0.487 | ||||
| Treatment group | 1 | 0.155 | .695 | 0.002 | |
| Mechanical symptoms | 1 | 1.310 | .255 | 0.014 | |
| Treatment group × mechanical symptoms | 1 | 0.489 | .486 | 0.005 | |
| EQ-VAS at baseline (covariate) | 1 | 81.599 | <.001 | 0.476 |
ADL, activities of daily living; DV, dependent variable; EQ-5D, EuroQol 5 dimensions; EQ-VAS, EuroQol visual analog scale; KOOS, Knee injury and Osteoarthritis Outcome Score; QoL, quality of life.
Change in Patient-Reported Outcome Measure Scores From Baseline to 5 Years by Mechanical Symptoms
| Surgery | Nonsurgery | Between-Group Difference | |
|---|---|---|---|
| KOOSPAIN | |||
| No mechanical symptoms | |||
| n | 20 | 15 | |
| Mean (95% CI) | 36.6 (28.4 to 44.7) | 26.9 (17.4 to 36.4) | 9.7 (–3.1 to 22.4) |
| | .136 | ||
| Mechanical symptoms | |||
| n | 45 | 19 | |
| Mean (95% CI) | 18.2 (12.8 to 23.5) | 27.5 (19.3 to 35.7) | –9.3 (–19.2 to 0.5) |
| | .063 | ||
| Within-group difference | |||
| Mean (95% CI) | 18.4 (8.7 to 28.1) | –0.6 (–13.0 to 11.9) | |
| |
| .925 | |
| KOOSSYMPTOMS | |||
| No mechanical symptoms | |||
| n | 19 | 16 | |
| Mean (95% CI) | 25.1 (17.3 to 33.0) | 20.6 (11.7 to 29.4) | 4.6 (–7.2 to 16.4) |
| | .445 | ||
| Mechanical symptoms | |||
| n | 46 | 19 | |
| Mean (95% CI) | 13.1 (8.0 to 18.2) | 24.2 (16.4 to 32.1) | –11.1 (–20.5 to –1.8) |
| |
| ||
| Within-group difference | |||
| Mean (95% CI) | 12.1 (2.7 to 21.4) | –3.6 (–15.6 to 8.3) | |
| |
| .545 | |
| KOOSADL | |||
| No mechanical symptoms | |||
| n | 20 | 16 | |
| Mean (95% CI) | 28.3 (21.1 to 35.5) | 17.1 (9.0 to 25.2) | 11.2 (0.1 to 22.3) |
| |
| ||
| Mechanical symptoms | |||
| n | 44 | 18 | |
| Mean (95% CI) | 14.1 (9.4 to 18.8) | 19.8 (12.4 to 27.2) | –5.7 (–14.5 to 3.1) |
| | .199 | ||
| Within-group difference | |||
| Mean (95% CI) | 14.2 (5.6 to 22.8) | –2.7 (–13.6 to 8.2) | |
| |
| .622 | |
| KOOSSPORTS | |||
| No mechanical symptoms | |||
| n | 20 | 14 | |
| Mean (95% CI) | 37.6 (25.5 to 49.8) | 32.4 (17.0 to 47.8) | 5.2 (–15.1 to 25.5) |
| | .611 | ||
| Mechanical symptoms | |||
| n | 45 | 19 | |
| Mean (95% CI) | 24.5 (16.5 to 32.5) | 27.9 (15.7 to 40.2) | –3.4 (–18.1 to 11.2) |
| | .641 | ||
| Within-group difference | |||
| Mean (95% CI) | 13.1 (–1.3 to 27.6) | 4.5 (–15.2 to 24.1) | |
| | .073 | .652 | |
| KOOSQoL | |||
| No mechanical symptoms | |||
| n | 20 | 15 | |
| Mean (95% CI) | 41.6 (31.1 to 51.1) | 31.5 (19.0 to 43.9) | 10.2 (–6.5 to 26.8) |
| | .229 | ||
| Mechanical symptoms | |||
| n | 45 | 19 | |
| Mean (95% CI) | 27.4 (20.5 to 34.3) | 31.3 (20.6 to 41.9) | –3.9 (–16.6 to 8.8) |
| | .547 | ||
| Within-group difference | |||
| Mean (95% CI) | 14.2 (1.8 to 26.7) | 0.2 (–16.0 to 16.5) | |
| |
| .978 | |
| EQ-5D | |||
| No mechanical symptoms | |||
| n | 19 | 15 | |
| Mean (95% CI) | 0.23 (0.15 to 0.31) | 0.22 (0.13 to 0.32) | 0.01 (–0.12 to 0.14) |
| | .886 | ||
| Mechanical symptoms | |||
| n | 45 | 19 | |
| Mean (95% CI) | 0.17 (0.12 to 0.23) | 0.24 (0.15 to 0.32) | –0.07 (–0.17 to 0.04) |
| | .201 | ||
| Within-group difference | |||
| Mean (95% CI) | 0.06 (–0.04 to 0.16) | –0.02 (–0.14 to 0.11) | |
| | .239 | .819 | |
| EQ-VAS | |||
| No mechanical symptoms | |||
| n | 19 | 14 | |
| Mean (95% CI) | 21.2 (15.1 to 27.3) | 20.3 (13.2 to 27.4) | 0.9 (–8.5 to 10.3) |
| | .846 | ||
| Mechanical symptoms | |||
| n | 44 | 18 | |
| Mean (95% CI) | 15.6 (11.6 to 19.6) | 18.9 (12.6 to 25.3) | –3.3 (–10.8 to 4.2) |
| | .385 | ||
| Within-group difference | |||
| Mean (95% CI) | 5.6 (–1.7 to 12.9) | 1.3 (–8.2 to 10.9) | |
| | .133 | .779 |
Bolded values indicate statistical significance (P < .05). Adjusted for overall mean scores at baseline. ADL, activities of daily living; EQ-5D, EuroQol 5 dimensions; EQ-VAS, EuroQol visual analog scale; KOOS, Knee injury and Osteoarthritis Outcome Score; QoL, quality of life.